See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636651_2025_Ovid_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001636651, Ovid Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,940,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 433,000 |
| 3 | remainder_Assets | 35,794,000 |
| 4 | LiabilitiesCurrent | 10,522,000 |
| 5 | LiabilitiesNoncurrent | 13,419,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,473,778 |
| 9 | ResearchAndDevelopmentExpense | 35,684,409 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 509,468 |
| 12 | remainder_NetIncome | 177,968,319 |
| 13 | remainder_ComprehensiveNetIncome | -4,131 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 92,167,000 |
| 1 | Liabilities | 23,941,000 |
| 2 | Expenses | 60,158,187 |
| 3 | Revenues | 509,468 |
| 4 | StockholdersEquity | 68,226,000 |
| 5 | NetIncome | 118,319,600 |
| 6 | ComprehensiveNetIncome | 118,317,534 |
| 7 | BaseVar | 177,374,052 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.60 |
| 9 | EconomicCapitalRatio | 4.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
